The relationship between inflammatory marker levels and pulmonary tuberculosis severity

Area of Science:

• Medical research
• Inflammation markers
• Tuberculosis diagnostics

Background:

• Pulmonary tuberculosis (PTB) poses a significant global health challenge.
• Accurate assessment of PTB severity is crucial for effective patient management.
• Novel biomarkers for inflammation and disease severity are needed.

Purpose of the Study:

• To investigate the correlation between red cell distribution width (RDW), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and other inflammatory markers with PTB severity.
• To evaluate the potential of RDW and NLR as indicators of PTB disease progression.

Main Methods:

• A comparative study involving 70 patients with active PTB and 50 healthy controls.
• Analysis of inflammatory markers including white blood cell count, neutrophil count, RDW, NLR, PLR, and C-reactive protein.
• Stratification of PTB patients into mild-to-moderate and advanced disease groups for comparison.

Main Results:

• Patients with advanced PTB exhibited significantly higher white blood cell counts, neutrophil counts, RDW, NLR, and C-reactive protein levels compared to those with mild-to-moderate PTB.
• Specifically, RDW (17.7% vs. 15.7%, p=0.002) and NLR (4.7 vs. 3.1, p=0.009) were notably higher in the advanced PTB group.
• No significant differences in age, gender, or smoking history were observed between PTB patients and controls.

Conclusions:

• RDW and NLR serve as valuable inflammatory markers for assessing PTB severity.
• These markers can potentially aid clinicians in managing TB patients and determining disease stage.
• Further research may validate RDW and NLR for routine use in PTB diagnostics and monitoring.